Program News
News and stories about the UNC Lineberger Multiple Myeloma & Amyloidosis Program
-
Multiple myeloma is a silent invader
Multiple myeloma is cancer of the immune system. Oncologist Sascha Tuchman, MD, MHS, shares what you need to know about the condition and treatment.
-
Studies identify barriers between doctors and their patients that limit clinical trial enrollment for Black people with blood cancers
Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.
-
Study identifies health care access barriers for older adults with multiple myeloma and their caregivers
A study led by UNC Lineberger’s Shakira Grant, MBBS, and colleagues found several barriers to high-quality cancer care for people with multiple myeloma and their caregivers.
-
Hematologist focuses on multiple myeloma, amyloidosis
Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.
-
Grant receives $200,000 NIH grant to study impact of multiple myeloma on older adults, care partners
UNC Lineberger’s Shakira Grant, MBBS, was awarded a two-year research grant to study the illness and treatment experiences of older adults with multiple myeloma and their care partners.
-
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.